期刊文献+

非特异型外周T细胞淋巴瘤1例并文献复习 被引量:2

Peripheral T-cell lymphoma unspecified:a case report and review of literatures
原文传递
导出
摘要 目的:提高以发热为主要表现的外周T淋巴瘤的诊断水平,并探讨其临床特点及治疗方法。方法:回顾性分析1例非特异型外周T细胞淋巴瘤诊治过程,结合文献复习,以期提高该病的诊治水平。结果:患者从发病到明确诊断1年余,病程中反复出现发热、皮疹、肝功能异常。经过2次淋巴结活检、1次脾脏穿刺,经病理免疫组织化学分析得以确诊。先后给予EPOCH、DICE、GemOx等一线、二线治疗方案,并应用抗血管新生药物血管内皮抑制素恩度辅助治疗,病情曾一度稳定。确诊8个月后,病情进展并发噬血细胞综合征死亡。结论:对于以发热、无痛性淋巴结肿大为主要表现的病例,同时伴有血清LDH、β2-微球蛋白明显升高,高度怀疑淋巴瘤时,应反复多次、多部位取活检。外周T细胞淋巴瘤对EPOCH方案化疗反应差,含有吉西他滨和铂类的GemOx方案可延缓病情进展,但维持时间短,淋巴瘤并发噬血细胞综合征预后差。 Objective:To improve the diagnostic level in peripheral T-cell lymphoma unspecified(PTCL-U)with unknown-reason fever as main clinical feature,and to explore the clinical characteristics and therapeutic method.Method: A case of PTCL-U was reported.The diagnostic and treatment course were retrospectively analyzed.The related literatures were reviewed for increasing recognition of the disease.Result:After suffering recurrent fever,rash and abnormal liver function for one year,the patient experienced biopsy of lymph node twice and aspirate of spleen once,she was diagnosed as peripheral T-cell lymphoma unspecified eventually by pathological immunohistochemistry.She received first-line and second-line regimens such as EPOCH,DICE,and GemOx chemotherapy.She also received anti angiogenesis agent Endstar.The disease was controlled for a time.But 8 months later,the primary disease became progressive and was complicated with hemophagocytic syndrome.Conclusion:If a patient presents with long term unknown origin fever,painless lymph node enlargement accompanied by serum LDH increasing,biopsy should be done repeatedly to identify the suspected lymphoma.The prognosis of PTCL-U is poor.In our experience,the effect of EPOCH regimen is limited,GemOx is effective in pretreated PTCL-U patient and can delay the progression of lymphoma,which offers an advantage over conventional chemotherapy.But the duration of response is of short time.The prognosis of PTCL-U will be worse if accompanied with hemophagocytic syndrome.
出处 《临床血液学杂志》 CAS 2012年第2期144-148,共5页 Journal of Clinical Hematology
关键词 淋巴瘤 T细胞 诊断 治疗 peripheral T-cell lymphoma unspecified diagnosis treatment
  • 相关文献

参考文献12

  • 1SAVAGE K J,CHHANABHAI M,GASCOYNE R D,etal.Characterization of peripheral T-cell lymphoma in asingle North American institution by the WHO classifica-tion[J].Ann Oncol,2004,15:1467-1475.
  • 2ESCALON M P,LIU N S,YANG Y,et al.Prognosticfactors and treatment of patients with T-cell non-Hodgkin lymphoma:the M D.Anderson cancer centerexperience[J].Cancer,2005,103:2091-2098.
  • 3RODRIGUEZ-ABREU D,FILHO V B,ZUCCA E.Pe-ripheral T-cell lymphomas,unspecified(or not otherwisespecified):a review[J].Hematol Oncol,2008,26:8-20.
  • 4WEISENBURGER D D,SAVAGE K J,HARRIS N L,etal.Peripheral T-cell lymphoma,not otherwise specified:areport of 340cases from the International Peripheral T-cell Lymphoma Project[J].Blood,2011,117:3402-3408.
  • 5SWERDLLOW S H,CAMPO E,HARRIS N L,et al.World Health Organization classification of heamatopoiet-ic and lymphoid tissues[M].4th Edition.France:Lyon,International Agency for Research on Cancer,2009:238-241.
  • 6JONGSMA T E,VERBURG R J,GEELHOED DUI-JVESTIJN P H.Castleman’s disease:a rare lymphopro-liferative disorder[J].Eur J Intern Med,2007,18:87-89.
  • 7EFTHIMIOUS P,PAIK P K,BIELORYL L.Diagnosisand management of adult onset Still’s disease[J].AnnalRheumatic Disease,2006,65:564-572.
  • 8GALLAMINI A,STELITANO C,CALVI R,et al.Pe-ripheral T-cell lymphoma unspecified(PTCL-U):a newprognostic model from a retrospective multicentric clinicalstudy[J].Blood,2004,103:2474-2479.
  • 9WENT P,AGOSTINELLI C,GALLAMINI A,et al.Marker expression in peripheral T-cell lymphoma:apro-posed clinical-pathologic prognostic score[J].J Clin On-col,2006,24:2472-2479.
  • 10ZINZANI P L,MUSURACA G,TANI M,et al.Phase IItrial of proteasome inhibitor bortezomib in patients withrelapsed or refractory cutaneous T-cell lymphoma[J].JClin Oncol,2007,25:4293-4297.

同被引文献5

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部